Search Results - "Karachunski, P.I"

G.P.167 by Connolly, A.M, Malkus, E.C, Schierbecker, J.R, Siener, C.A, Anand, P, Mendell, J.R, Flanigan, K.M, Golumbek, P.T, Zaidman, C.M, McDonald, C.M, Henricson, E, Johnson, L, Nicorici, A, Karachunski, P.I, Day, J.W, Kelecic, J.M, Lowes, L.P, Alfano, L.N, Darras, B.T, Kang, P.B, Florence, J.M

“…Few clinical trials involve non-ambulatory boys and men with Duchenne muscular dystrophy. We previously tested clinical outcomes in 91 subjects and found…”
Get full text

P.7.16 One year outcome assessment of young boys with DMD using the Bayley-III Scales of Infant and Toddler Development by Connolly, A.M, Florence, J.M, Cradock, M.M, Malkus, E.C, Schierbecker, J.R, Siener, C.A, Wulf, C.O, Anand, P, Golumbek, P.T, Zaidman, C.M, Lowes, L.P, Alfano, L.N, Viollet-Callendret, L, Flanigan, K.M, Mendell, J.R, McDonald, C.M, Goude, E, Johnson, L, Nicorici, A, Karachunski, P.I, Day, J.W, Dalton, J.C, Farber, J.M, Buser, K.K, Darras, B.T, Kang, P.B, Riley, S.O, Shriber, E, Parad, R, Bushby, K, Eagle, M, DMD, M.D.A

“…Clinical trials currently underway in Duchenne muscular dystrophy (DMD) almost always exclude infants and young boys because traditional outcome measures rely…”
Get full text

G.P.167: Clinical trial readiness for non-ambulatory boys and men with Duchenne muscular dystrophy: 12 and 24 month follow-up from the MDA–DMD Network by Connolly, A.M., Malkus, E.C., Schierbecker, J.R., Siener, C.A., Anand, P., Mendell, J.R., Flanigan, K.M., Golumbek, P.T., Zaidman, C.M., McDonald, C.M., Henricson, E., Johnson, L., Nicorici, A., Karachunski, P.I., Day, J.W., Kelecic, J.M., Lowes, L.P., Alfano, L.N., Darras, B.T., Kang, P.B., Florence, J.M.

“…Few clinical trials involve non-ambulatory boys and men with Duchenne muscular dystrophy. We previously tested clinical outcomes in 91 subjects and found…”
Get full text